These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 904673)

  • 41. Current Status of Therapeutic Drug Monitoring of 5-Fluorouracil Prodrugs.
    Hashimoto Y; Yoshida Y; Yamada T; Aisu N; Yoshimatsu G; Yoshimura F; Hasegawa S
    Anticancer Res; 2020 Aug; 40(8):4655-4661. PubMed ID: 32727789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A case of an adverse reaction to topical 5-fluorouracil in irradiated skin.
    Lambert T; Mullinax K; Smith J
    J Drugs Dermatol; 2006 Mar; 5(3):282-3. PubMed ID: 16573264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier.
    Romagosa R; Saap L; Givens M; Salvarrey A; He JL; Hsia SL; Taylor JR
    Dermatol Surg; 2000 Apr; 26(4):338-40. PubMed ID: 10759821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.
    Simon JC; Dominicus R; Karl L; Rodríguez R; Willers C; Dirschka T
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):881-9. PubMed ID: 25257941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topical chemotherapy with 5-fluorouracil. A review.
    Goette DK
    J Am Acad Dermatol; 1981 Jun; 4(6):633-49. PubMed ID: 7016939
    [No Abstract]   [Full Text] [Related]  

  • 46. Validation of Photograph-Based Toxicity Score for Topical 5-Fluorouracil Cream Application.
    Pomerantz H; Korgavkar K; Lee KC; Lew R; Weinstock MA;
    J Cutan Med Surg; 2016 Sep; 20(5):458-66. PubMed ID: 27207349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Desensitization to 5-fluorouracil.
    Eppinger T; Sperber K
    Allergy Asthma Proc; 1999; 20(3):189-91. PubMed ID: 10389552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantification of 5-FU in skin samples for the development of new delivery systems for topical cancer treatment.
    Petrilli R; Eloy JO; Paschoal JAR; Lopez RFV
    Pharmazie; 2018 Mar; 73(3):133-138. PubMed ID: 29544559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study.
    Parrozzani R; Lazzarini D; Alemany-Rubio E; Urban F; Midena E
    Br J Ophthalmol; 2011 Mar; 95(3):355-9. PubMed ID: 20693564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of genital condylomata with topical 5-fluorouracil.
    Krebs HB
    Dermatol Clin; 1991 Apr; 9(2):333-41. PubMed ID: 1647908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical 5-fluorouracil is ineffective in the treatment of extensive alopecia areata.
    Kaplan AL; Olsen EA
    J Am Acad Dermatol; 2004 Jun; 50(6):941-3. PubMed ID: 15153898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current management using 5-fluorouracil: 1985.
    Bennett R; Epstein E; Goette D; Lowe N; Maibach H; Menn H; Tromovitch T
    Cutis; 1985 Sep; 36(3):218-22, 227-9, 233-6. PubMed ID: 4053687
    [No Abstract]   [Full Text] [Related]  

  • 53. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil.
    Powers R; Gordon R; Roberts K; Kovach R
    Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sensitization to low dose 5-fluorouracil. Subsequent enhancement of its systemic antitumor effect in the rat.
    Falk RE; Hardy M; Makowka L; Teodorczyk-Injeyan J; Falk JA
    J Clin Invest; 1982 Sep; 70(3):558-67. PubMed ID: 7107895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 5-Fluorouracil chemotherapy and pelvic radiation in the treatment of large bowel cancer. Decreased toxicity in combined treatment with 5-fluorouracil administration through the intraperitoneal route.
    Sugarbaker PH; Gianola FJ; Barofsky I; Hancock SL; Wesley R
    Cancer; 1986 Aug; 58(4):826-31. PubMed ID: 3521842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Periconceptional exposure to topical 5-fluorouracil.
    Otaño L; Amestoy G; Paz J; Gadow EC
    Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):263-4. PubMed ID: 1733205
    [No Abstract]   [Full Text] [Related]  

  • 57. Topical chemotherapy.
    Jansen GT
    Clin Dermatol; 1992; 10(3):305-7. PubMed ID: 1483249
    [No Abstract]   [Full Text] [Related]  

  • 58. Laser-assisted delivery of synergistic combination chemotherapy in in vivo skin.
    Wenande E; Tam J; Bhayana B; Schlosser SK; Ishak E; Farinelli WA; Chlopik A; Hoang MP; Pinkhasov OR; Caravan P; Rox Anderson R; Haedersdal M
    J Control Release; 2018 Apr; 275():242-253. PubMed ID: 29454062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topical delivery of 5-fluorouracil (5-Fu) by 3-alkylcarbonyl-5-Fu prodrugs.
    Beall HD; Sloan KB
    Int J Pharm; 2001 Apr; 217(1-2):127-37. PubMed ID: 11292549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Penetration enhancing effect of tetrahydrogeraniol on the percutaneous absorption of 5-fluorouracil from gels in excised rat skin.
    Hanif RM; Qineng P; Zhan G
    J Control Release; 1998 Nov; 55(2-3):297-302. PubMed ID: 9795085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.